Has Stephen Hohmann, MD received payments from drug or device companies?

Yes. Drug and device makers reported $587,217 in general payments to Stephen Hohmann, MD across 593 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Hohmann, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Hohmann, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Hohmann, MD

Vascular Surgery · Dallas, TXNPI 1114020922

Payments from drug & device makers

$587,217in general payments, 2019–2025

Across 593 payments — averaging $990.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bard Peripheral Vascular, Inc.$413K
Merit Medical Systems Inc$134K
Medtronic$18K
C. R. Bard, Inc. & Subsidiaries$14K
W. L. Gore & Associates, Inc.$4K
Mozarc Medical US LLC$1K
plus $5K from 46 others

$402in research payments, 2019–2025

Across 2 payments — averaging $200.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$350
Sonavex, Inc.$52

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bard Peripheral Vascular, Inc.	277	$412,714
Merit Medical Systems Inc	56	$133,626
Medtronic(2 entities)	78	$17,560
C. R. Bard, Inc. & Subsidiaries	8	$13,586
W. L. Gore & Associates, Inc.	20	$3,761
Mozarc Medical US LLC	3	$1,010
Sonavex, Inc.	4	$679
Axogen	19	$461
Johnson & Johnson(2 entities)	23	$394
Silk Road Medical, Inc.	7	$298
Terumo Medical Corporation	2	$213
Imperative Care, Inc	7	$206
Bolton Medical Inc	2	$198
Boston Scientific	2	$141
C. R. Bard Foundation, Inc.	1	$140
Abbott	7	$134
Shape Memory Medical Inc.	1	$126
Cardiva Medical, Inc.	1	$125
Cook Medical LLC	4	$124
Cvrx, Inc.	5	$123
Stryker	5	$120
E.r. Squibb & Sons, L.L.C.	8	$117
Pfizer	8	$112
Baylis Medical Technologies Inc.	1	$111
Heartflow, Inc.	1	$110
Tactile Systems Technology Inc	4	$71
Endologix LLC	1	$69
Balt USA, LLC	3	$65
Abiomed	1	$61
Angiodynamics, Inc.	3	$59
Surmodics, Inc.	2	$57
Baxter Healthcare	2	$53
Philips North America LLC	2	$53
Ossur Americas, Inc.	2	$52
Livanova USA, Inc.	1	$49
Resmed Corp	2	$46
Novartis	2	$43
Venturemed Group, Inc.	1	$37
Acell, Inc.	2	$32
Polynovo North America LLC	2	$32
Lemaitre Vascular, Inc.	1	$32
Smith+Nephew	2	$32
Shockwave Medical, Inc	1	$28
Avinger Inc.	1	$23
Integra Lifesciences Corporation	1	$20
Penumbra, Inc.	1	$18
Davol Inc.	1	$18
EKOS Corporation	1	$17
Reprise Biomedical, Inc.	1	$16
Covidien LP	1	$15
Cashflow Solutions, LLC	1	$14
Reflow Medical Inc	1	$14

How this compares

$587,217 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$193,903

Medicare patients

403

Services billed

1,106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Dallas

Gregory PearlDallas$2.3M
Michael SiahDallas$838K
Dennis GableDallas$547K
Carlos TimaranDallas$527K
William ShutzeDallas$106K
Bradley GrimsleyDallas$101K
John KedoraDallas$101K
John EidtDallas$100K
Alton BurnsDallas$98K
Javier VasquezDallas$92K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →